mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.2 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.2 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.2 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.2 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
0.21 |
0.2 |